The molecular weights or shapes of Factor X preparations determined by gel filtration were dependent on the density of the BaSO4 used for the initial adsorption from serum. One form obtained with BaSO4 of density 2g/ml behaved as if it had a molecular weight of 39000 and possessed preformed clotting activity (Factor Xa), whereas that of the form adsorbed with BaSO4 of density 1g/ml had a molecular weight of 69000 and consisted of inactive Factor X precursor. Thus degradation accompanied by activation seems to occur as a result of surface adsorption on high-density BaSO4 and is associated with an interchange of protein between the two bands observed electrophoretically. The clotting and esterase activities measurable in vitro after complete activation were not matched by a corresponding ability to induce thrombus formation and 'lethality' in vivo. The most effective preparations of Factor X in this respect possessed preformed activity, which was enhanced in the presence of phospholipid. Factor X lost activity more rapidly in dilute solution, and its concentration at the surface of phospholipid micelles probably decreases loss by dilution in circulating blood.
Factor X occupies a central place in the final pathways of coagulation leading to prothrombin activation, and there is some evidence to suggest that, owing to this position, it may be involved in the generation of a hypercoagulable state in vivo (Barton et al., 1970) . It is generally prepared from bovine plasma together with prothrombin by adsorption on BaSO4 followed by ion-exchange chromatography, and the product from this source was shown by Esnouf & Williams (1962) to possess esterase activity towards tosylarginine methyl ester. In contrast, Lundblad & Davie (1965) reported that, when prepared from bovine prothrombin-poor serum, Factor X possessed no activity towards this substrate.
Serum also contains an agent referred to as serum thrombotic accelerator, which may be related to Factor X and which is capable of inducing a state of hypercoagulability in experimental animals (Reimeretal., 1960; Howell & Scott, 1964) . However, earlier work on the isolation of serum thrombotic accelerator from pig serum (Howell & Scott, 1966) showed that it has a molecular weight ten times that of Factor X; therefore on this basis they are not comparable.
Tlhe present paper presents a scheme for the further purification of Factor X from pig serum after its initial adsorption on various grades of BaSO4 (Howell & Dupe, 1972) . In addition to describing some of its properties from this source, an attempt is made to clarify the nature of the thrombotic state by defining its relationship to serum thrombotic accelerator in terms of clotting activity in vivo.
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Materials and Methods
Materials
Pig blood was used exclusively and was collected from the abattoir in glass containers. It was left to clot spontaneously and then kept for 20h at 4°C to destroy thrombin before being centrifuged at 2500g for 5min to separate serum. In the case of plasma the separation was identical except that for the collection of blood, sodium oxalate (0.1 M) was placed in the glass containers (1 vol. to 9vol. of blood). BaSO4 for X-ray analysis and soil testing respectively was obtained from BDH Chemicals Ltd., Poole, Dorset, U.K.
Methods
Preparation of BaSO4-adsorbable protein. Proteins adsorbable on BaSO4 were prepared by the method of Howell & Scott (1964) except that the citrate concentration used for protein elution was decreased to 0.06M at pH 5.8. The resulting eluates are referred to according to whether X-ray-or soil-testing-grade BaSO4 was used. However, owing to its lower content of protein and absence of lipoprotein the main purification was attempted from soil-testing grade BaSO4, and X-ray-grade BaSO4 was used in some preparations for comparative purposes only. The importance of defining the density of the solid BaSO4 used for the adsorption of clotting factors was discussed by Howell & Dupe (1972) . The bulk density ofthe solid X-ray-grade BaSO4 normally used for clotting-factor adsorption is 1 .Og/ml, whereas the value for the soil-testing-grade material should be at least 2.0g/ml. Natural barytes of this density was also kindly supplied by Barium Chemicals Ltd., Widnes, Lancs., U.K. Precipitation. Precipitation with (NH4)2SO4 was done by the method of Howell & Scott (1964) . The fraction precipitated between 33 and 60% saturation was dialysed against 25mM-Tris-HCl buffer, pH 8.0.
Column chromatography. DEAE-cellulose (Whatman DE-23) was obtained from Reeve Angel and Co. Ltd., London E.C.4, U.K. Precycling was carried out as recommended by the manufacturer with final equilibration in 25mM-Tris-HCl buffer, pH 8.0. The ion exchanger was originally packed to a height of 24cm in glass columns (2.0cm x 30cm), but later the packed height was limited to 16cm, as this gave improved separations. The fraction precipitated by (NH4)2SO4 (10-15 ml) was washed on to the column with 10-20ml of 0.025M-Tris-HCl, pH8.0, and was then eluted with a linear gradient consisting of NaCl and trisodium citrate in increasing concentration. The reservoir contained 300ml of 0.36M-NaCl and 0.096M-sodium citrate in 0.025M-Tris-HCl buffer, pH 8.0, and the mixing chamber contained 300ml of the same buffer but without NaCl and citrate. The flow rate was maintained at 60ml/h and the E280 of the effluent was monitored continuously with a Uvicord II absorptiometer (LKB Instruments Ltd.). Fractions (5 ml) were collected and those containing Factor X were pooled and concentrated for the subsequent stage by ultrafiltration.
Gel filtration. Sephadex G-200 (medium grade; Pharmacia, London W.5, U.K.) was sieved to obtain the 200-300-mesh fraction and was allowed to swell for 3 days at room temperature before packing it in a Lucite column (3cm x 35cm) with no dead space. For gel filtration the column was used at a flow rate of 15ml/h and the eluting buffer was 0.025M-Tris-HCI, pH8.0, with 0.2M-NaCl. In later preparations 0.025M-CaCl2 was added to the eluting buffer to obtain a high-molecular-weight component in an active coagulable state. The eluate was collected in 3 ml fractions and those containing coagulant activity were pooled and concentrated. The Sephadex G-200 column was calibrated with Blue Dextran 2000, Yellow Dextran, vitamin B12, fibrinogen, bovine serum albumin, immunoglobulin G, trypsin and cytochrome c, which were passed through the column sequentially to obtain a plot of the ratio of Ve to VO against the logarithm of their molecular weight (Andrews, 1964 Phospholipidanddigitonin. L-oa-Phosphatidylcholine from soya beans was obtained from Sigma (London) Chemical Co., London S.W.6, U.K. and was prepared as a 5 % (w/v) emulsion in 0.15 M-NaCl by ultrasonic treatment for 1 min at a frequency of 20 kHz in an M.S.E. ultrasonic disintegrator. The emulsion was stored before use for not more than 3-4 days at 4°C. It was used either alone or in combination with digitonin (BDH Chemicals Ltd.) and was added to solutions of Factor X immediately before infusion into animals as a substitute for phospholipid normally supplied by platelets (Howell & Dupe, 1971a) .
Clotting assays in vitro. Total Factor X was determined by the technique of Bachmann et al. (1958) by using Russell's-viper venom combined with a mixed phospholipid preparation from brain as a complete thromboplastin. The partial thromboplastin time was a modification of this assay in which Russell's-viper venom was omitted from the above thromboplastin reagent. This enabled preformed Factor X activity (Factor Xa) to be measured, 1 unit of activity being defined as the amount present in 1.Oml of serum or plasma fully activated with Russell's-viper venom. Unknown samples were measured by reference to a Factor Xa dilution curve obtained by using the Bachmann et al. (1958) assay. All clotting reagents were obtained from Diagnostic Reagents Ltd., Thame, Oxon, U.K. Russell'sviper venom was obtained from The Wellcome Foundation, Beckenham, Kent, U.K., and was reconstituted as recommended.
Thermal stability. This was investigated for Factor X activity by preincubating the sample for various time-intervals up to 1 h at 50°and 60°C before assaying for clotting activity at 370C in the usual manner.
Clotting assays in vivo. These were performed as described by Howell & Dupe (1971a) by using male Sprague-Dawley rats weighing 140-160g. Test material either alone or with platelet substitute was injected into the inferior vena cava. After 10min clot production in the isolated portal vein was estimated as 1 (+) where up to one-half of the vessel was occupied with clot, to 2 (+) where the whole length of it was filled. More potent infusions that killed the animal within 5 and 2min were assayed as 3 (+) and 4 (+) respectively. In the latter cases additional thrombin could be identified at the site of injection and elsewhere in the venous system. Protein determination. The E280, or the colorimetric procedure of Goa (1955) (10,ul) were made until the Factor X preparation was fully activated (Fig. 1) . The same amount of venom necessary to cause activation in vitro was then used to activate preparations for assay in vivo.
Electrophoresis. This was done in 0.5 % agarose in sodium barbitone buffer, pH8.4 (I0.05). The gel was dissolved in the buffer by heating them over a steam bath, and then the solution was cooled to 50°C before being poured into an immunoelectrophoresis tray (Shandon Scientific Co. Ltd., London N.W.10, U.K.) containing eight microscope slides. Electrophoresis was done at 30-4OmA and 160V for 40-60min, and the protein was then stained for 5-10min in Trichrome (Fischl & Gabor, 1963) followed by destaining in 5 % and 2 % (v/v) acetic acid respectively. Esterase activity. This was determined towards two amino acid esters, Tos-Arg-OMe* (Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K.) and Z-Tyr-ONp (BDH Chemicals Ltd.), on a Unicam SP. 800 spectrophotometer equipped with scale expansion and a recorder, by measuring the E250 and E400 respectively. Comparative studies were performed at a single substrate concentration of7 and 0.3 mi respectively to ensure zero-order kinetics; for kinetic studies with Z-Tyr-ONp alone the substrate concentrations were varied from 0.1 to 1.0 mm. The Km and Vmax. were calculated by the method of Lineweaver & Burk (1934) . The reaction cuvette was maintained at 35°C and contained 2.7ml of 0.05M-Tris-HCI buffer, pH 8.0, 0.1 ml ofsubstrate and0.2ml of a solution containing purified Factor X (1.Omg/ ml); water replaced Factor X in the control cuvette. Esterase activity was measured by following the rate of product formation continuously for a given timeperiod, and the initial rates of reaction were determined by noting the change in slope of extinction relative to the water blank. The rate of any spontaneous hydrolysis in buffer alone was determined separately against a water blank and subtracted. The change in absorbance per unit time was related to standard curves prepared by using known amounts of pure p-nitrophenol at pH 8.0.
In an attempt to characterize further the relationship between esterase and Factor X activity the effect of both substrates as competitive inhibitors of the latter were tested by means of the Bachmann et al. (1958) (Howell & Scott, 1964; protein elutedfrom Dupe, 1972 (Table 1) .
(NH4)2S04 precipitation. A 2-3-fold purification was obtained (Table 1) .
DEAE-cellulose chromatography. The separations for proteins originating from soil-testing and X-ray grades of BaSO4 on a column of bed length 16cm is shown in Figs. 2(a) and 2(b) respectively. Factor X in all cases was eluted towards the trailing edge of the run in fractions 90-1 10 for the former separation and 110-130 for the latter. Factor X required the presence of citrate ions in addition to NaCl for elution, otherwise recovery was low, indicating irreversible adsorption. It was eluted at the same gradient strength regardless ofwhether protein eluted from soil-testinggrade BaSO4 or X-ray-grade BaSO4 was used as the starting material.
At this stage the specific activity was increased 2500 times compared with that of the original pig serum (Table 1) .
Gel filtration. As the material from the previous stage contained another protein that was eluted in the same position as Factor X, further purification was attempted by filtration through Sephadex G-200. This procedure also provided information on the physical nature of the various Factor X preparations obtained (Fig. 3) .
The protein that was eluted before Factor X during the Sephadex G-200 stage was similar to material observed by Howell & Scott (1966) when protein eluted from soil-testing-grade BaSO4 was separated on cellulose phosphate. However, gel filtration of the other fractions eluted from the DEAE-cellulose revealed that the bulk of this high-molecular-weight protein had been eluted before Factor X in the preceding stage. Thus filtration ofthe fraction containing Factor X through a Sephadex G-200 column merely provided a further small yield of this material, which possesses a molecular weight ofapprox. 380000 and activity in a one-stage prothrombin assay towards pig plasma artificially depleted of Factor V.
Properties of isolated Factor X Table 2 summarizes the properties of purified Factor X obtained from serum and plasma by using different grades of BaSO4, and shows that the assay methods differentiated between non-activated and preactivated forms. In this study eluates prepared from serum by using BaSO4 of density 2g/ml in the first stage yielded preparations of Factor X that possessed preformed activity and which was eluted from Sephadex G-200 in approximately the same position as Yellow Dextran (marker 4, mol.wt. 40000). In contrast, when BaSO4 of density 1 g/ml was used Factor X possessed little preformed activity and was eluted from Sephadex G-200 very close to bovine serum albumin (marker 5, mol.wt. 68000).
The relationship between Vel Vo and the logarithm of the molecular weight of the various Factor X preparations is shown in Fig. 3 . The position of markers 4 and 5, which were nearest to the Factor X obtained with each grade of BaSO4 specified, is , protein (E280); e, Factor X activity as measured in a Bachmann et al. (1958) assay; units as defined in Table 1 . (b) 33-60%-satd.-(NH4)2SO4-precipitable protein from an X-ray-grade BaSO4 eluate separated and assayed as for (a), except that the gradient was applied at fraction 38. shown. The anomalous clotting behaviour of impure Factor X obtained by using batches of BaSO4 with densities outside the specified limits has been reported (Howell & Dupe, 1972) and was apparent as an alteration in the ratio of Factor X/Xa. The preparation which extended the upper limit to 80000 was the only exception in that this was obtained from pig plasma by using X-ray-grade BaSO4 with a normal specification of 1 g/ml. In contrast to the preparations eluted around marker 4, none of those eluted around marker 5 exhibited preformed clotting activity.
The altered elution pattern caused by adsorption to higher-density BaSO4 could be due to a change in shape of the molecule to a more compact form and/or a decrease in the molecular weight. It is noteworthy Vol. 133 that dehydration of a Factor X preparation during acetone precipitation, although not altering the apparent size of the molecule, did increase the preformed clotting activity ( Table 2 ). The presence of significant amounts of carbohydrate ranging from 7 to 9 % (Table 2) remained constant and independent of the grade of BaSO4 used.
Homogeneity. Electrophoretically the purified fraction obtained from protein eluted from soil-testinggrade BaSO4 separated as a single band in the ,-globulin region together with a much fainter band detectable in the albumin region. Factor X from protein eluted from X-ray-grade BaSO4 showed the same qualitative pattern, except that the secondary band in the albumin position was more intense. The column was equilibrated with 0.025M-Tris-HCl buffer, pH8.0 containing 0.2M-NaCl. The hatched areas, \ \ \ \ (for ten determinations) and //// (for five determinations), indicate preparations from a soil-testinggrade-BaSO4 eluate and an X-ray-grade-BaSO4 eluate respectively. The widths indicate the range of variation obtained with batches of BaSO4 whose densities were later found to be outside the specified limits of 2.0 and 1.Og/ml respectively. The mean value in each case was 39000 and 69000. Total volume of the column (Vs) was 180ml and void volume (VO) was 55ml. Flow rate was 15ml/h and 3.Oml fractions were collected. Numbers indicate positions of markers: 1, vitamin B12; 2, cytochrome c; 3, trypsin; 4, Yellow Dextran; 5, bovine serum albumin; 6, y-globulin; 7, fibrinogen; 8, Blue Dextran ---; shows non-linear region of the graph. (Table 4) The use of insolubilized trypsin for the activation of Factor X in impure eluates from X-ray-grade and soil-testing-grade BaSO4 was described by Howell & Dupe (1971b) , but it was sometimes difficult to activate fully the purified Factor X obtained in the present work by this means.
Clot production in vivo. The results of experiments to determine the ability of Factor X preparations to produce red coagulation thrombus in vivo both before and after proteolytic activation is shown in Table 3 . Neither Factor X nor phospholipid was thrombogenic when injected alone, whereas 1.0 unit of Factor X in combination with 1.0mg of phospholipid/ml induced sufficient clot formation to fill the isolated portal vein. Also, addition of the surfactant digitonin to the L-a-phosphatidylcholine in a molar ratio of 1:2 respectively (Howell & Dupe, 1971a) increased the potency of the infusate, which killed the animal (4+), and post-mortem examination revealed a very extensive clot at the site ofinjection as well as in both sides of the heart and elsewhere in the venous system. Similar extensive clot formation that killed the animal could be induced when the amount of Factor X infused was doubled while the concentration of the phospholipid was kept at a constant value of 1.0mg/ ml. However, a decrease of the Factor X infusate to 0.5 unit at this concentration ofphospholipid brought its concentration below the threshold necessary for clot promotion, as did the serial dilution of the phospholipid at a constant Factor X concentration Table 3 . Activity ofpurified Factor X in vivo The preparations used for the assays were obtained from soil-testing-grade BaSO4 (density 2.0g/ml) and therefore contained preformed Factor Xa activity. The bioassay was performed as described in the text. The mean clot formation score is shown and the number of rats used in each determination is shown in parentheses. In preparation (3), complete activation of Factor X was achieved by preincubation with 5.0,ul of Russell's-viper venom 
Trace (2) 0 (2)t 0 (2) 0 (2) * The surfactant digitonin (0.4mg/ml) was added to the platelet substitute soya-bean phospholipid. The total volume injected was maintained at 2.0ml by dilution with 0.15M-NaCl. Table 4 . Activity of Factor Xfrom pig serum and plasma towards Z-Tyr-ONp ester at pH8.0 and 350C together with kinetic parameters for activity derivedfrom eluates from soil-testing-grade BaSO4 Total Factor X activity and preformed activity were determined and expressed in units as in Table 2 of 1 unit. The infusion of 2 units of Factor Xa obtained after complete activation with Russell'sviper venom failed to produce any thrombus in vivo even in the presence of phospholipid, which suggests that the assay in vivo is more discriminating than the test in vitro in measuring the total physiological effectiveness.
Esterolytic action of Factor X. Activity towards amine esters was studied by using Tos-Arg-OMe and Z-Tyr-ONp, since the latter was found most useful in work with impure preparations (Howell & Dupe, 1972) . In agreement with these earlier studies, we could not detect activity of purified Factor Xa from pig serum towards Tos-Arg-OMe, as reported by Esnouf & Williams (1962) for Factor Xa separated from bovine plasma. Preparations from protein eluted from soil-testing-grade BaSO4 that possessed preformed clotting activity caused higher rates of hydrolysis of Z-Tyr-ONp and also acetone precipitation increased the activity towards Z-Tyr-ONp (Table 4 ). Vma.. and Km were calculated with this substrate for preparations of Factor X from protein eluted from soil-testing-grade BaSO4; the values were close to each other.
Both Tos-Arg-OMe and Z-Tyr-ONp inhibited clotting activity in vitro, the latter ester (Fig. 5) being most effective; p-nitrophenol, the product of any hydrolysis, did not inhibit coagulation.
Thermal denaturation studies on Factor Xpreparations. After 1 h at 50°C there was no loss in clotting activity, whereas at 60'C decay of activity occurred (Fig. 6) .
Loss of esterase activity towards Z-Tyr-ONp was also measured at 60°C to compare it with the corresponding decrease in clotting activity. After 20min at 60°C a typical sample of Factor X had lost 90% of its clotting activity and 25 % of its esterase activity. (Howell & Dupe, 1972) i satisfactory yield of Factor X by performing the whole purification in 3 days without using protease inhibitors such as di-isopropyl fluorophosphate, used by to prevent autoproteolysis. However, it is likely that some degradation occurred during the present purification procedure, in view of the low-molecular-weight peptide material that migrated to the cathode on agarose gel (Fig. 4) .
The electrophoretic mobilities of the two major bands (Fig. 4) agree with similar observations of Papahadjopoulos etal. (1964) , who noted.the presence of two components in purified Factor X from human plasma together with a transfer of protein from the fast to the slower moving band on activation with trypsin. Similarly we found that substitution of lowfor high-density BaSO4 caused a corresponding interchange of protein between the two bands. These results together with those from differential clotting assays and gel filtration suggest that the two bands represent precursor (X) and activated (Xa) forms. Thus the differences reported in the literature for the molecular weight of Factor X could arise from experimental variations involving use ofdifferent grades of BaSO4.
There is some controversy as to whether Factor X preparations possess esterase activity, as Lundblad & Davie (1965) reported no esterase activity towards synthetic amine substrates in a preparation from serum. Esnouf & Williams (1962) noted the appearance of activity towards Tos-Arg-OMe in samples obtained from bovine plasma. In the present study, although activity towards Z-Tyr-ONp was established, no esterase activity towards Tos-Arg-OMe was found either in the activated or preactivated state, and it appears that the detection of esterase activity is dependent on both the substrate used and the origin of the Factor X. However, both Z-Tyr-ONp and Tos-Arg-OMe caused inhibition of the clotting activity of Factor X preparations in vitro, indicating that with Tos-Arg-OMe binding occurred even though no hydrolysis resulted. The kinetic studies with Z-TyrONp indicated that the Km value was unaffected, whereas that for Vmax. increased as a result of activation with insolubilized trypsin.
With preparations from protein eluted from X-raygrade BaSO4, which possessed limited amounts of preformed Factor Xa activity, specific esterase activity was ten times lower than that from protein eluted from soil-testing-grade BaSO4, which has a considerable amount of Factor Xa activity. This study indicated that hydrolytic activity towards Z-Tyr-ONp had a good correlation with the coagulant activity of Factor X, except for material concentrated by acetone precipitation, where the esterase activity was increased, in contrast to the clotting activity, which was unchanged. Thermal denaturation studies on Factor X preparations at 60°C also support the idea of closely associated sites for both activities, since a decrease in clotting activity was also accompanied by decreased esterase activity; however, caution is needed when interpreting the exact relationship between loss of these two activities measured as units, since they are not directly compatible.
Factor X was kept as concentrated as possible during the purification because of the rapid decay of Factor Xa, which occurred in dilute solutions, and which could result in a complete loss in activity over comparatively short periods of time. The dependence of activity on concentration may indicate that decay ofactivity caused by rapid dilution in the blood could be important in vivo as a clearing mechanism for activated Factor X. The optimum production of thrombus which occurred either in the presence of phospholipid (Barton et al., 1970) or with a combination of phospholipid and digitonin (Howell & Dupe, 1971a) could result from Factor Xa attachment to the surface of these micellar-forming substances as described by Jobin & Esnouf (1967) . Thus by preventing its removal, activity can be maintained until thrombus accumulates. The high-molecularweight protein (>350000) associated with a portion of the Factor X was similar to serum thrombotic accelerator separated by Howell & Scott (1966) by using cellulose phosphate chromatography; recent experiments with Sephadex G-200 equilibrated with 0.025 M-CaCl2 to separate the high-molecular-weight material from Factor X have shown that it possesses an independent clotting activity measurable in vitro.
This investigation was supported by a grant from The British Heart Foundation.
